中文 | English
Return
Total: 63 , 1/7
Show Home Prev Next End page: GO
Author:( Wenxia ZHOU)

1.Expression and function of protease-activated receptor-2 on tumor cells

Wenxia SHI ; Hong ZHOU

Cancer Research and Clinic 2008;20(9):646-648

2.Applications of RNAi technology in Alzheimer’s diseases

Yan SUN ; Wenxia ZHOU ; Yongxiang ZHANG

Chinese Pharmacological Bulletin 2003;0(11):-

3.Medical countermeasures against chemical threats:a review of antidotes

Wenxia ZHOU ; Gang LIU ; Yongxiang ZHANG

Chinese Journal of Pharmacology and Toxicology 2016;30(12):1411-1418

4.Progress in the study on D-serine in CNS

Sheng YANG ; Wenxia ZHOU ; Yongxiang ZHANG

Chinese Pharmacological Bulletin 2003;0(08):-

5.The effects of Liuwei Dihuang decoction on the differential expression genes in the hippocampus of senescence-accelerated mouse

Xiaorui CHENG ; Wenxia ZHOU ; Yongxiang ZHANG

Chinese Pharmacological Bulletin 2003;0(08):-

6.The relationship of vesicular glutamate transporters and nervous system disease

Xiaorui CHENG ; Wenxia ZHOU ; Yongxiang ZHANG

Chinese Pharmacological Bulletin 1987;0(03):-

7.Advances in biomarkers of oxidative stress under sulfur mustard exposure

Yizhou MEI ; Xiaorui ZHANG ; Wenxia ZHOU ; Yongxiang ZHANG

Military Medical Sciences 2014;(5):392-395

8.Roles of adenosine receptors in Alzheimer's disease.

Rong YAN ; Zengyao HU ; Wenxia ZHOU ; Qi WANG ; Yongxiang ZHANG

Acta Pharmaceutica Sinica 2014;49(6):751-6

9.Establishment of the metabolic syndrome rodent model

Yan GUO ; Xiaoli CHI ; Yuan MA ; Wenxia ZHOU ; Yongxiang ZHANG

Chinese Pharmacological Bulletin 2010;26(4):551-556

10.Research progress in the relationship of autocrine motility factor,autocrine motility factor receptor and the nervous system

Xuan SHAO ; Xiaoli CHI ; Wenxia ZHOU ; Yongxiang ZHANG

Chinese Pharmacological Bulletin 2009;25(12):1541-1545

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 63 , 1/7 Show Home Prev Next End page: GO